Join us in Philadelphia this month for this conference about molecular targets and cancer therapeutics.
One in Five Young, Non-Hispanic White Women Who Tan Indoors Are Dependent on Indoor Tanning
AACR Congratulates Norman (“Ned”) Sharpless, MD, on Being Sworn in as Director of the National Cancer Institute
AACR Helped to Launch Philadelphia’s First Love Lock “Hope Fence”
Stand Up To Cancer Catalyst® Launches 10 Clinical Trial Projects Combining Cancer Treatments from Nine Different Pharmaceutical Companies to Explore Innovative Approaches and Find New Indications for Blockbuster Drugs to Improve Patient Outcomes
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2017
2017 AACR Philadelphia Marathon, Nov. 17-18, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
AACR Annual Meeting 2018, April 14-18, 2018
This Cancer Research Catalyst blog post discusses efforts to find efficient, noninvasive ways to identify patients who are likely to benefit from this form of immunotherapy.
STAT News covered a recent study in the AACR’s journal Cancer Discovery that identified risk factors for neurotoxicity following CAR T-cell therapy, a finding that could improve how doctors manage this dangerous side effect.